Experimental models of oculomotor dysfunction in the rhesus monkey.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D003337:Corpus Callosum / Q000502:physiology; D004195:Disease Models, Animal; D005128:Eye Diseases; D005133:Eye Movements; D005143:Eyelids / Q000187:drug effects / Q000502:physiology; D005725:Ganglia, Autonomic / Q000502:physiology; D006145:Guanethidine / Q000494:pharmacology; D006980:Hyperthyroidism / Q000503:physiopathology; D008253:Macaca mulatta; D009069:Movement Disorders; D009759:Nystagmus, Pathologic; D009802:Oculomotor Nerve / Q000502:physiology*; D009886:Ophthalmoplegia; D010830:Physostigmine / Q000494:pharmacology; D011149:Pons / Q000502:physiology; D011680:Pupil
D000317:Adrenergic alpha-Antagonists; D010830:Physostigmine; D006145:Guanethidine